Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product

Transfusion

Volumn 47, Issue 7, 2007, Pages 1268-1275

  Calmels, Boris ^a   Lemarié, Claude ^b   Esterni, Benjamin ^b   Malugani, Caroline ^b   Charbonnier, Aude ^b   Coso, Diane ^b   Schiano De Colella, Jean Marc ^b   Deconinck, Eric ^b   Caillot, Denis ^b   Viret, Frédéric ^b   Ladaique, Patrick ^b   Lapierre, Valérie ^b   Chabannon, Christian ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL COUNT; CELL ISOLATION; CLINICAL TRIAL; COHORT ANALYSIS; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; DISEASE SEVERITY; FEMALE; FLUSHING; FREEZING; GRANULOCYTE; HEADACHE; HEART ARREST; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT SAFETY; PROSPECTIVE STUDY; PRURITUS; QUALITY CONTROL; RATING SCALE; SEIZURE; SOLID TUMOR; SYNCOPE; THAWING; THORAX PAIN; THROAT IRRITATION; TREMOR; UNCONSCIOUSNESS; VERTIGO; VISUAL IMPAIRMENT; VOMITING;

ADOLESCENT; ADULT; AGED; BLOOD CELL COUNT; BLOOD COMPONENT REMOVAL; DATA COLLECTION; DIMETHYL SULFOXIDE; FEMALE; GRANULOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY CONTROL; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, AUTOLOGOUS;

EID: 34250649214     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01267.x     Document Type: Article

References (39)

1. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006 37 : 439 49.
2. Corso S, Vukelja SJ, Wiener D, Baker WJ. Diffuse alveolar hemorrhage following autologous bone marrow infusion. Bone Marrow Transplant 1993 12 : 301 3.
3. Miniero R, Vai S, Giacchino M, et al. Severe respiratory depression after autologous bone marrow infusion. Haematologica 1992 77 : 98 9.
4. Higman MA, Port JD, Beauchamp NJ Jr., Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000 26 : 797 800.
5. Windrum P, Morris TC. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 2003 31 : 315.
6. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994 45 : 187 8.
7. Nishihara G, Sakemi T, Ikeda Y, et al. Multiple organ failure associated with dimethylsulfoxide and hydroxyethyl starch in autologous blood stem cell transplantation. Nephron 1996 72 : 356 7.
8. Bauwens D, Hantson P, Laterre PF, et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005 46 : 1671 4.
9. Zenhausern R, Tobler A, Leoncini L, et al. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000 79 : 523 6.
10. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000 25 : 1285 7.
11. Sauer-Heilborn A, Kadidlo D, McCullough J. Patient care during infusion of hematopoietic progenitor cells. Transfusion 2004 44 : 907 16.
12. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991 31 : 521 6.
13. Zambelli A, Poggi G, Da Prada G, et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998 18 : 4705 8.
14. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990 75 : 781 6.
15. Ferrucci PF, Martinoni A, Cocorocchio E, et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000 25 : 173 7.
16. Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002 42 : 1573 80.
17. Martino M, Morabito F, Messina G, et al. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica 1996 81 : 59 61.
18. Martin-Henao GA, Torrico C, Azqueta C, et al. Cryopreservation of hematopoietic progenitor cells from apheresis at high cell concentrations does not impair the hematopoietic recovery after transplantation. Transfusion 2005 45 : 1917 24.
19. Beaujean F, Hartmann O, Kuentz M, et al. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991 8 : 291 4.
20. Rodriguez L, Velasco B, Garcia J, Martin-Henao GA. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 2005 45 : 1391 7.
21. Lemarie C, Calmels B, Malenfant C, et al. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate. Transfusion 2005 45 : 737 42.
22. Calmels B, Houze P, Hengesse JC, et al. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003 31 : 823 8.
23. Syme R, Bewick M, Stewart D, et al. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004 10 : 135 41.
24. Hequet O, Dumontet C, El Jaafari-Corbin A, et al. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002 29 : 544.
25. Olivero S, Alario T, Ladaique P, et al. CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol. Bone Marrow Transplant 1999 23 : 387 94.
26. Windrum P, Morris TC, Drake MB, et al. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005 36 : 601 3.
27. Lopez-Jimenez J, Cervero C, Munoz A, et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994 13 : 789 93.
28. Thome S, Craze J, Mitchell C. Dimethylsulphoxide-induced serum hyperosmolality after cryopreserved stem-cell graft. Lancet 1994 344 : 1431 2.
29. Keung YK, Lau S, Elkayam U, et al. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 1994 14 : 363 7.
30. Frim J, Mazur P. Approaches to the preservation of human granulocytes by freezing. Cryobiology 1980 17 : 282 6.
31. Tsvetkov T, Nickolov C, Buckureshtliev A, et al. Aggregate formation in cryopreserved leukocyte suspensions. Cryobiology 1985 22 : 35 9.
32. Price TH. Granulocyte transfusion therapy. J Clin Apher 2006 21 : 65 71.
33. Strauss RG, Connett JE, Gale RP, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 1981 305 : 597 603.
34. Price TH, Bowden RA, Boeckh M, et al. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 2000 95 : 3302 9.
35. Moraes TJ, Zurawska JH, Downey GP. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 2006 13 : 21 7.
36. David NA. The pharmacology of dimethyl sulfoxide. Annu Rev Pharmacol 1972 12 : 353 74.
37. Rowley SD, Prather K, Bui KT, et al. Collection of peripheral blood progenitor cells with an automated leukapheresis system. Transfusion 1999 39 : 1200 6.
38. Wilke R, Brettell M, Prince HM, et al. Comparison of COBE Spectra software version 4.7 PBSC and version 6.0 auto PBSC program. J Clin Apher 1999 14 : 26 30.
39. Milone G, Pinto V, Mercurio S, et al. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cell in infused suspension and on patient age. Blood 2006 108 : 402b.